Quanterix Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test

Quanterix Corporation announced that the FDA has expanded the Emergency Use Authorization label for its Simoa® SARS-CoV-2 N Protein Antigen Test to include testing with nasal swab and saliva samples, and for asymptomatic serial testing with nasal swab samples.